Jeff Garro
Stock Analyst at Stephens & Co.
(0.82)
# 4,030
Out of 5,154 analysts
59
Total ratings
31.58%
Success rate
-13.63%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Maintains: Equal-Weight | $17 → $10 | $6.74 | +48.37% | 5 | Mar 6, 2026 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $3 → $2 | $1.18 | +69.49% | 2 | Feb 27, 2026 | |
| CERT Certara | Maintains: Overweight | $15 → $12 | $7.06 | +69.97% | 6 | Dec 12, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $23.27 | +37.52% | 6 | Dec 4, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $3.17 | +183.91% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $12.05 | +165.56% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $12.22 | +63.67% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $18.77 | +49.17% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $195.49 | +43.23% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $1.95 | +156.41% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $25.34 | +117.05% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $174.49 | +43.27% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.69 | -13.66% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $5.08 | +451.18% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $18.44 | +8.46% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $8.98 | -56.57% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $0.76 | +297.30% | 3 | May 6, 2022 |
OptimizeRx
Mar 6, 2026
Maintains: Equal-Weight
Price Target: $17 → $10
Current: $6.74
Upside: +48.37%
Definitive Healthcare
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $1.18
Upside: +69.49%
Certara
Dec 12, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $7.06
Upside: +69.97%
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.27
Upside: +37.52%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $3.17
Upside: +183.91%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $12.05
Upside: +165.56%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $12.22
Upside: +63.67%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $18.77
Upside: +49.17%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $195.49
Upside: +43.23%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.95
Upside: +156.41%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $25.34
Upside: +117.05%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $174.49
Upside: +43.27%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.69
Upside: -13.66%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $5.08
Upside: +451.18%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $18.44
Upside: +8.46%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $8.98
Upside: -56.57%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $0.76
Upside: +297.30%